Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
As of close of business last night, Sotera Health Co’s stock clocked out at $16.84, down -0.53% from its previous closing price of $16.93. In other words, the price has decreased by -$0.53 from its previous closing price. On the day, 1.35 million shares were traded. SHC stock price reached its highest trading level at $17.24 during the session, while it also had its lowest trading level at $16.755.
Ratios:
To gain a deeper understanding of SHC’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 15.89 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 41.69. For the most recent quarter (mrq), Quick Ratio is recorded 2.16 and its Current Ratio is at 2.38. In the meantime, Its Debt-to-Equity ratio is 4.14 whereas as Long-Term Debt/Eq ratio is at 4.10.
Upgrades & Downgrades
In the most recent recommendation for this company, BMO Capital Markets on November 13, 2025, initiated with a Outperform rating and assigned the stock a target price of $19.
On May 05, 2025, Goldman Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $17.
On December 06, 2024, Goldman started tracking the stock assigning a Neutral rating and target price of $14.Goldman initiated its Neutral rating on December 06, 2024, with a $14 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 03 ’25 when GTCR CO-INVEST XI LP bought 41,219 shares for $16.33 per share.
GTCR FUND XI/A LP bought 5,143,033 shares of SHC for $83,985,729 on Dec 03 ’25. On Dec 03 ’25, another insider, WARBURG PINCUS LLC, who serves as the Affiliate of the company, bought 9,720,000 shares for $16.84 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SHC now has a Market Capitalization of 4784141824 and an Enterprise Value of 6764239872. As of this moment, Sotera’s Price-to-Earnings (P/E) ratio for their current fiscal year is 87.25, and their Forward P/E ratio for the next fiscal year is 17.84. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 6.18. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.16 while its Price-to-Book (P/B) ratio in mrq is 8.69. Its current Enterprise Value per Revenue stands at 5.88 whereas that against EBITDA is 12.424.
Stock Price History:
The Beta on a monthly basis for SHC is 1.83, which has changed by 0.30481696 over the last 52 weeks, in comparison to a change of 0.12415576 over the same period for the S&P500. Over the past 52 weeks, SHC has reached a high of $17.78, while it has fallen to a 52-week low of $9.53. The 50-Day Moving Average of the stock is 3.71%, while the 200-Day Moving Average is calculated to be 24.19%.
Shares Statistics:
It appears that SHC traded 2.31M shares on average per day over the past three months and 2039910 shares per day over the past ten days. A total of 284.09M shares are outstanding, with a floating share count of 203.78M. Insiders hold about 28.27% of the company’s shares, while institutions hold 57.50% stake in the company. Shares short for SHC as of 1763078400 were 7742768 with a Short Ratio of 3.34, compared to 1760486400 on 7248497. Therefore, it implies a Short% of Shares Outstanding of 7742768 and a Short% of Float of 5.0200000000000005.
Earnings Estimates
A comprehensive evaluation of Sotera Health Co (SHC) is underway, with the input of 8.0 analysts contributing to its current rating.The consensus estimate for the next quarter is $0.17, with high estimates of $0.18 and low estimates of $0.17.
Analysts are recommending an EPS of between $0.84 and $0.83 for the fiscal current year, implying an average EPS of $0.84. EPS for the following year is $0.94, with 8.0 analysts recommending between $0.97 and $0.92.
Revenue Estimates
In. The current quarter, 7 analysts expect revenue to total $299.17M. It ranges from a high estimate of $299.9M to a low estimate of $298M. As of. The current estimate, Sotera Health Co’s year-ago sales were $290.2MFor the next quarter, 7 analysts are estimating revenue of $269.74M. There is a high estimate of $277.17M for the next quarter, whereas the lowest estimate is $262.36M.
A total of 7 analysts have provided revenue estimates for SHC’s current fiscal year. The highest revenue estimate was $1.16B, while the lowest revenue estimate was $1.16B, resulting in an average revenue estimate of $1.16B. In the same quarter a year ago, actual revenue was $1.1BBased on 7 analysts’ estimates, the company’s revenue will be $1.23B in the next fiscal year. The high estimate is $1.24B and the low estimate is $1.21B.
